TRANSLIT partner presents poster at the 16th Australian Peptide Conference
We are pleased to announce that Mohsen Hosseini, member of the TRANSLIT project team at Vrije Universiteit Brussel (VUB), presented a poster entitled “Peptidomimetics to inhibit the SLIT2-ROBO1 interaction as a gateway to attenuate pancreatic adenocarcinoma” at the 16th Australian Peptide Conference, held in Launceston, Australia, on 13 October 2025. (https://www.peptides2025.org/) This work, carried out […]
TRANSLIT consortium meets in Brussels for in-person progress meeting
15 May 2025 – Brussels, BelgiumThe TRANSLIT consortium held its 2025 in-person meeting at Hoek38 in Brussels on May 15, 2025. Representatives from all partner institutions participated in a full-day program featuring updates on each work package, including presentations on biomarker discovery, mechanistic studies, and therapeutic strategies targeting the SLIT-ROBO signaling pathway in pancreatic cancer. […]
TRanSLIT Project Showcased at Toulouse Onco Week 2025
2 posters on the TRanSLIT project were presented during meeting ‘Insight Outside’ during the Toulouse Onco week from February 5th-7th, 2025 Toulouse, France. One poster was by the hand of Selina Mader, PhD student from Prof. Ilse Rooman’s lab at Translational Oncology Research Centre, VUB Brussels. Also postdoctoral researcher Agathe Quesnel from the Prof. Corinne […]
Pancreatic cancer stroma: looking at the neighbor to face the problem
At the 19th ASEICA International Congress, Prof. Elisa Espinet (University of Barcelona & IDIBELL) gave an oral presentation titled “Pancreatic cancer stroma: looking at the neighbor to face the problem.” The conference was organized in Zaragoza, Spain from 13 ot 15 November 2024.The presentation highlighted research on tumor–stroma interactions and their role in pancreatic cancer […]
ROBO1 Drives Gemcitabine Resistance in Pancreatic Cancer
Selina Mader, PhD student in the lab of Prof. Rooman, VUB; Belgium, presented on this TRanSLIT project at 4th German Pancreatic Cancer Research Meeting – An Else Kröner Symposium by KFO5002 and CCC-N. Her results entitled ‘ROBO1 Drives Gemcitabine Resistance in Pancreatic Cancer’ were presented as a poster and flash talk on June 17 to June 19, […]
TRanSLIT Research Featured at European Pancreatic Club 2024 in Spain
Two posters were presented at the European Pancreatic Club (EPC) meeting in Santiago de Compostela, Spain from June 26th-29th 2024. PhD student Michela Felaco, from the lab of Prof. Luca Cardone, CNR, Italy, presented the results entitled “Deciphering the SLIT/ROBO mediated immunosuppressive tumor microenvironment to enhance immunotherapy via drug repurposing in pancreatic ductal adenocarcinoma”. Postdoctoral […]
TRANSLIT researcher presents poster at ISCO 2024 in Barcelona
Sandra Garcia-Mulero, postdoctoral researcher in the lab of Prof. Elisa Espinet at the Bellvitge Biomedical Research Institute (IDIBELL), Spain, presented a poster entitled“Integrative single-cell and spatial analysis to study SLIT-ROBO guidance cues in the immune modulation of pancreatic cancer” at the ISCO 2024 Conference, held in Barcelona, Spain. The presentation highlights the integrative, multi-omics strategies […]
TRanSLIT Results Presented at BE-PRECISE 2024 in Antwerp
During the first edition of the Belgian Precision and Personalized Oncology Meeting BE-PRECISE in Antwerp, Belgium, PhD student Selina Mader presented a poster presentation entitled “ROBO1 Drives Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma”, putting her results of this TRanSLIT project in the picture.
Insights into pancreatic cancer shared at ASEICA 2023
Prof. Elisa Espinet (University of Barcelona & Bellvitge Biomedical Research Institute – IDIBELL, Spain) presented a poster at the ASEICA Anniversary Congress 2023 (November) in A Coruña, Spain (conference website The poster highlighted advances from the TRANSLIT collaboration between IDIBELL (P6) and Vrije Universiteit Brussel (P1), focusing on the molecular and cellular mechanisms driving pancreatic […]
Kick-off symposium TRANSCAN-3 JTC-2021
On October 17-18, 2023 the Kick-off symposium of the ERA-NET activity TRANSCAN-3 on the topic ” Next generation cancer immunotherapy: targeting the tumor microenvironment ” was organized by the Latvian Science Council in cooperation with the Italian Ministry of Health. The meeting took place at the University of Latvia in Riga. More than 70 top […]
First results presented by Dr. Eva Rodriguez Aznar at Gordon Research Conference
On April 30- May 5 2023 the biannual Pancreatic Disease Gordon Research Conference was organized in Lucca, Italy. This year the conference was focused on ‘Understanding Cell Behavior and Communication’ in pancreatic diseases with the goal of gaining insights into how the systemic and local environment impact endocrine and exocrine cells in health and disease. […]